151 related articles for article (PubMed ID: 25117301)
1. Administration of commercial Rhodococcus equi specific hyperimmune plasma results in variable amounts of IgG against pathogenic bacteria in foals.
Sanz MG; Oliveira AF; Page A; Horohov DW
Vet Rec; 2014 Nov; 175(19):485. PubMed ID: 25117301
[TBL] [Abstract][Full Text] [Related]
2. Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia.
Sanz MG; Oliveira AF; Loynachan A; Page A; Svansson V; Giguère S; Horohov DW
Equine Vet J; 2016 Jan; 48(1):103-8. PubMed ID: 25257622
[TBL] [Abstract][Full Text] [Related]
3. VapA-specific IgG and IgG subclasses responses after natural infection and experimental challenge of foals with Rhodococcus equi.
Sanz MG; Villarino N; Ferreira-Oliveira A; Horohov DW
Vet Immunol Immunopathol; 2015 Mar; 164(1-2):10-5. PubMed ID: 25681111
[TBL] [Abstract][Full Text] [Related]
4. Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals.
Sanz MG; Loynachan A; Horohov DW
Vet Rec; 2016 Mar; 178(11):261. PubMed ID: 26932206
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a peptide-ELISA based upon N-terminal B-cell epitope of the VapA protein for diagnosis of Rhodococcus equi pneumonia in foals.
Phumoonna T; Muscatello G; Chicken C; Gilkerson JR; Browning GF; Barton MD; Heuzenroeder MW
J Vet Med B Infect Dis Vet Public Health; 2006 Apr; 53(3):126-32. PubMed ID: 16629724
[TBL] [Abstract][Full Text] [Related]
6. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
Cauchard J; Sevin C; Ballet JJ; Taouji S
Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia.
Hooper-McGrevy KE; Giguere S; Wilkie BN; Prescott JF
Am J Vet Res; 2001 Aug; 62(8):1307-13. PubMed ID: 11497456
[TBL] [Abstract][Full Text] [Related]
8. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia.
Prescott JF; Nicholson VM; Patterson MC; Zandona Meleiro MC; Caterino de Araujo A; Yager JA; Holmes MA
Am J Vet Res; 1997 Apr; 58(4):356-9. PubMed ID: 9099378
[TBL] [Abstract][Full Text] [Related]
9. Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia.
Kahn SK; Cywes-Bentley C; Blodgett GP; Canaday NM; Turner-Garcia CE; Vinacur M; Cortez-Ramirez SC; Sutter PJ; Meyer SC; Bordin AI; Vlock DR; Pier GB; Cohen ND
PLoS One; 2021; 16(8):e0250133. PubMed ID: 34437551
[TBL] [Abstract][Full Text] [Related]
10. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.
Lopez AM; Hines MT; Palmer GH; Knowles DP; Alperin DC; Hines SA
Vaccine; 2003 Sep; 21(25-26):3815-25. PubMed ID: 12922115
[TBL] [Abstract][Full Text] [Related]
11. Recognition of a B-cell epitope of the VapA protein of Rhodococcus equi in newborn and experimentally infected foals.
Phumoonna T; Barton MD; Heuzenroeder MW
J Vet Med B Infect Dis Vet Public Health; 2005 Aug; 52(6):291-5. PubMed ID: 16219093
[TBL] [Abstract][Full Text] [Related]
12. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma.
Perkins GA; Yeager A; Erb HN; Nydam DV; Divers TJ; Bowman JL
Vet Ther; 2002; 3(3):334-46. PubMed ID: 12447842
[TBL] [Abstract][Full Text] [Related]
13. Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi.
Hooper-McGrevy KE; Wilkie BN; Prescott JF
Vaccine; 2005 Dec; 23(50):5760-7. PubMed ID: 16112256
[TBL] [Abstract][Full Text] [Related]
14. Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals.
Caston SS; McClure SR; Martens RJ; Chaffin MK; Miles KG; Griffith RW; Cohen ND
Vet Ther; 2006; 7(4):361-75. PubMed ID: 17216591
[TBL] [Abstract][Full Text] [Related]
15. Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses.
Prescott JF; Fernandez AS; Nicholson VM; Patterson MC; Yager JA; Viel L; Perkins G
Equine Vet J; 1996 Sep; 28(5):344-9. PubMed ID: 8894530
[TBL] [Abstract][Full Text] [Related]
16. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.
Haghighi HR; Prescott JF
Vet Immunol Immunopathol; 2005 Apr; 104(3-4):215-25. PubMed ID: 15734542
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals.
Giguère S; Gaskin JM; Miller C; Bowman JL
J Am Vet Med Assoc; 2002 Jan; 220(1):59-63. PubMed ID: 12680449
[TBL] [Abstract][Full Text] [Related]
18.
Sanz MG; Bradway DS; Horohov DW; Baszler TV
Vet Rec; 2019 Jul; 185(1):19. PubMed ID: 30995996
[No Abstract] [Full Text] [Related]
19. Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins.
Hooper-McGrevy KE; Wilkie BN; Prescott JF
Clin Diagn Lab Immunol; 2003 May; 10(3):345-51. PubMed ID: 12738629
[TBL] [Abstract][Full Text] [Related]
20. Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi.
Taouji S; Nomura I; Giguère S; Tomomitsu S; Kakuda T; Ganne V; Takaï S
Vaccine; 2004 Mar; 22(9-10):1114-23. PubMed ID: 15003638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
